dMMR/MSI CRC develops from germline mutations in MMR genes (MLH1, MSH2, MSH6, PMS2) and has unique features, including a preference for the proximal colon, poor differentiation, and abundance of tumor-infiltrating lymphocytes (Kawakami et al., 2015). This evidence concerns the gene PMS2 and colorectal carcinoma.